improving health and medicine
NeuroQuest to Begin US Clinical Validation Trials for Alzheimer's Blood Test
A blood test for early detection of Alzheimer’s disease, based on Prof. Michal Schwartz’s research, exceeded Alzheimer’s Association standards in recent trials. Now, NeuroQuest, the firm behind the test, has announced it will be working with UC San Diego on clinical validation. The test may be able to identify the disease many years earlier.
December 10, 2015